Ye Weiguo
Gyre Therapeutics, Inc. · Chief Operating Officer
Ye Weiguo is listed in filings as Chief Operating Officer at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including sale activity. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Mar 11, 2025 to May 27, 2026. Reported amounts are shown as $3.0K to $2.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $21k3.5k shares | SellMay 22, 2026 | $6.08 | $5.74 | |
| $79k12.8k shares | SellMay 21, 2026 | $6.15 | $5.74 | |
| $58k9.1k shares | SellMay 19, 2026 | $6.37 | $5.74 | |
| $1.3k200 shares | SellMay 18, 2026 | $6.62 | $5.74 | |
| $87k13.1k shares | SellMay 15, 2026 | $6.65 | $5.74 | |
| $108k15.6k shares | SellMay 14, 2026 | $6.91 | $5.74 |